Palbace 125mg Capsule (Palbociclib)

Overview:
Palbace 125mg Capsule is a CDK4/6 inhibitor containing Palbociclib. It works by blocking proteins (CDK4 and CDK6) that promote cancer cell division, thereby slowing the growth and spread of breast cancer cells. It is commonly prescribed alongside aromatase inhibitors or fulvestrant in postmenopausal women and certain men.

Uses:

• Treatment of HR-positive, HER2-negative advanced or metastatic breast cancer.

• Used in combination with aromatase inhibitors as initial endocrine-based therapy.

• Used with fulvestrant in patients whose disease has progressed after hormone therapy.

Dosage & Administration:

• Take exactly as prescribed by your oncologist.

• Usually taken once daily for 21 days, followed by 7 days off (28-day cycle).

• Take with food and swallow the capsule whole.

• Do not crush, chew, or open the capsule.

Precautions:

• Inform your doctor if you have liver disease, infections, or low blood counts.

• Regular blood tests are required to monitor white blood cell levels.

• Possible side effects include low white blood cells (neutropenia), fatigue, nausea, hair thinning, mouth sores, or infections.

• Avoid grapefruit and grapefruit juice during treatment.

• Use effective contraception and avoid pregnancy during therapy.

• Store in a cool, dry place, away from light and moisture.

Why Choose Palbace 125mg Capsule?

• Clinically proven CDK4/6 inhibitor

• Significantly slows breast cancer progression

• Oral capsule for convenient treatment

• Widely used in modern breast cancer therapy

Package Includes:

• Each pack contains 21 capsules of 125mg Palbace (Palbociclib)